The guide

Light lamp for winter blues: what the studies show

Evidence level: Weak.

Bright light improved depression scores on average in trials involving adults with seasonal affective disorder, abbreviated SAD (Pjrek et al., 2020). Those trials had moderate-to-high risk of bias (Pjrek et al., 2020). They do not establish a reliable benefit for everyone feeling tired during winter.

Here, Weak describes our confidence in applying this evidence to an ordinary winter-blues reader and their home lamp. It is Hallow’s editorial assessment, not a formal GRADE rating from the review. Evidence for diagnosed SAD and evidence for everyday tiredness are different questions.

If low mood persists or you suspect depression, speak with a clinician. Hallow explains research; it does not diagnose depression or prescribe its care. We earn nothing from devices: no affiliate links and no device sponsors.

Written 30 October 2026. Three research papers appear below, followed by clinical information and its limits. The papers are not three independent sets of participants; the review may include trials described separately.

The research

Pjrek and colleagues, 2020, Psychotherapy and Psychosomatics

PubMed 31574513

Design: Systematic review of 19 randomized trials in adults with SAD (Pjrek et al., 2020).
Light: Bright light of at least 1,000 lux, compared with dim light or sham/low-density negative ions (Pjrek et al., 2020). Trial protocols varied; the review did not test one universal home-lamp schedule.
What it showed: The pooled depression-score analysis favored bright light and included 18 studies with 610 patients (Pjrek et al., 2020). The standardized mean difference was −0.37, with a 95% confidence interval from −0.63 to −0.12 (Pjrek et al., 2020). This is a standardized score difference, not a 37% reduction in symptoms.
What it did not show: A guaranteed benefit for an individual, or an optimal exposure for every lamp. Moderate heterogeneity and moderate-to-high risk of bias limit confidence (Pjrek et al., 2020). The findings do not establish that every otherwise healthy person with winter fatigue benefits.

Lam and colleagues, 2006, American Journal of Psychiatry

Original paper · PMID 16648320

Design: Eight-week randomized, double-blind trial involving 96 adults with winter-pattern major depressive disorder (Lam et al., 2006).
Light: One group received 10,000-lux white light for 30 min each morning plus a placebo capsule (Lam et al., 2006). The comparison group received 100-lux light plus fluoxetine, an antidepressant (Lam et al., 2006). These are trial conditions, not instructions to start, stop, or replace medication.
What it showed: The primary depression-score analysis and response/remission rates showed no statistically significant between-group differences (Lam et al., 2006).
What it did not show: Formal equivalence between light and fluoxetine. There was no group receiving both dim light and a placebo capsule (Lam et al., 2006). The comparison therefore cannot isolate the absolute benefit attributable to bright light. The study’s distance and exposure cannot be transferred automatically to another lamp.

Rastad, Ulfberg and Lindberg, 2011, Depression Research and Treatment

Full paper · PMC3123908

Design: Descriptive secondary analysis involving 49 participants assessed as having SAD or subsyndromal SAD (Rastad et al., 2011). Forty-seven supplied complete longitudinal data (Rastad et al., 2011).
Light: Participants used a light room, not a home lamp (Rastad et al., 2011). The parent trial initially compared immediate exposure with a waiting list that later received exposure (Rastad et al., 2011).
What it showed: Fatigue and sleepiness scores improved after exposure in the merged treated groups (Rastad et al., 2011).
What it did not show: A placebo-adjusted fatigue benefit. The reported fatigue analysis pooled treated groups rather than comparing them with a concurrent untreated group (Rastad et al., 2011). It did not sample everyone who feels tired in winter. It cannot establish how much a home lamp would help that broader population.

What the lamp label cannot tell you

A 10,000-lux label does not establish equivalence with a studied device. Distance matters: follow the specific lamp’s instructions rather than borrowing another device’s distance (Mayo Clinic Staff, 2022). A red-light mask is not the white-light box described in SAD guidance (National Institute of Mental Health, 2023). Do not convert a lux label into a skin-light dose or an invented exposure schedule.

Clinical information describes common practice, not a personalized routine. NIMH describes UV-filtered 10,000-lux light for approximately 30–45 min, usually first thing in the morning (National Institute of Mental Health, 2023). Mayo describes typical recommendations of 20–30 min within the first waking hour (Mayo Clinic Staff, 2022). These descriptions differ and do not establish one uniquely optimal duration.

The review’s 1,000-lux inclusion rule is not a proven minimum effective brightness (Pjrek et al., 2020). Below 10,000 lux is not automatically unstudied; a 10,000-lux label is not proof of benefit (Pjrek et al., 2020). Mayo describes a brightness–duration tradeoff but supplies no proportional conversion formula (Mayo Clinic Staff, 2022). Do not multiply minutes to compensate for a lower lux label.

Sources: NIMH: Seasonal affective disorder, revised 2023; Mayo Clinic: Choosing a light box, 30 March 2022.

Guidance does not speak with one voice

NIMH describes light therapy among options for winter-pattern SAD (National Institute of Mental Health, 2023). NICE calls efficacy evidence uncertain when someone prefers light therapy over antidepressants or psychological treatment for winter depression (NICE, recommendation 1.4.39). That recommendation remains marked 2009; it is not a newly conducted review. This is a difference between clinical information and guidance, not a NICE prohibition.

Source: NICE NG222, use of light therapy.

Where the evidence stops

These sources do not establish one optimal duration, distance, or timing for every reader and lamp. They do not settle long-term benefit after stopping, device equivalence, or uncommon harms. Short, selected studies cannot establish universal safety. Everyday winter tiredness should not inherit depression-trial response rates.

For a different light question, read Does red light therapy work? Its skin-focused studies do not answer the winter-depression question.

Before using a lamp

Discuss light-box use with a clinician if you have bipolar disorder; inappropriate exposure can trigger manic symptoms (Mayo Clinic Staff, 2022). Certain eye conditions or photosensitizing medicines may require alternatives or medical supervision (National Institute of Mental Health, 2023). Mayo advises keeping eyes open without looking directly at the light (Mayo Clinic Staff, 2022). Follow the manufacturer’s distance and UV-safety instructions, and discuss eye problems with an eye specialist (Mayo Clinic Staff, 2022).

Persistent low mood belongs in a clinical conversation, not an app-generated schedule. Do not change prescribed care based on this guide.

Hallow’s lamp flow shows research examples and safety limits, not personal exposure settings. It does not verify your lamp’s output or calculate minutes from its lux label. After sign-in, Today lets you log lamp sessions you chose using device instructions and clinician guidance. The week bar records sessions without prescribing a weekly target. A journal records use; it cannot establish that the lamp caused a change in mood.

Hallow cannot provide a validated depression protocol or establish that your lamp will improve mood. Hallow Coach costs EUR 7 per month; a subscription is not depression care.

AI agents build and run Hallow on NanoCorp, with research limits stated alongside the findings.

Explore my device